II.
Experiments in the intact dog. Am. J, Physiol. 230(6): 1630-1636. 1976 . -Insulin metabolism in man is usually investigated by peripheral injection of the hormone, whereas native insulin undergoes hepatic extraction prior to mixing in the general circulation.
To quantify this difference, in 10 dogs ['z51 ]insulin was injected into a peripheral vein, and the initial distribution volume (IDV), the metabolic clearance rate (MCR), and the mean transit time (f) were computed from the plasma disappearance curve of the immunoprecipitable activity. The splenic vein was then cannulated under pentobarbital anesthesia, and the parameters were again computed from the peripheral activity after portal introduction of the tracer. The MCR after portal injection [lS.l -+-(SE) 1.1 mllmin per kg] was greater (P < 0.003) than the MCR after peripheral administration (13.4 * 0.9 ml/min per kg). Also, IDV was larger (p < 0.01) after portal injection (167 * 12 vs. 138 t 10 ml/kg). Mean transit times did not change significantly.
Insulin secretion rate (0,29 * 0.04 mU/min per kg) and body insulin mass (7.03 t 1.5 mu/kg) were also measured. An estimate of hepatic extraction was obtained from the difference between the clearance rate values calculated following portal and peripheral injection. Under our experimental conditions, hepatic retention of insulin was found to be 19.6% (range 9.6-36.2%). The method is recommended for investigations in man.
metabolic clearance rate; insulin delivery rate; hepatic retention; body insulin mass; hepatic handling of insulin, portal IRI concentrations THE LIVER IS THE MOST important site of insulin degradation (2, 3, 20, 23) , and pancreatic hormones must traverse the hepatic bed prior to mixing in the general circulation. As a consequence, hepatic removal markedly contributes to the determination of the amount of insulin secreted by the pancreas which is made available to peripheral tissues (1, 20) .
On the other hand, when insulin is parenterally administered, the amount circulating through the liver and its hepatic degradation are significantly smaller.
In vivo kinetic studies on insulin metabolism basically hinge upon the plasma disappearance curve recorded after the peripheral introduction of either native (32, 41, 46, 48) or labeled (10, (43) (44) (45) insulin. By this approach, the tracer hormone does not follow the endogenous secretion pathway; hence, the estimated kinetic parameters are expected to bear a systematic error.
We have thought it worthwhile to appraise the type and magnitude of this error. We have measured the metabolic cle arance rate, the initial distribution volume, and the mean transit time of insu lin after injection of [1z*51]insulin both via a peripheral vein and via the portal vein. This experi mental design was chosen in order to reproduce both the physiological and the artificial pattern, as brought about by parenteral administration The dog was selected as the experimental model, since it has been shown that insulin kinetics are quite similar in dog and in man (43).
The results have been interpreted on the basis of a minimum-assumption mathematical model presented in the accompanying paper (33); it has been demonstrated that hepatic extraction can be estimated from the difference between the clearance rates measured after portal and after peripheral injection. Insulin secretion rate and body insulin mass have also been calculated. The technique here described, which allows for in vivo measurement of hepatic retention of insulin, should provide information of physiological interest, In fact, while a considerable body of evidence has been accumulated showing that hepatic handling of insulin plays a central role in carbohydrate homeostasis (7, 13), a controversy still exists as to whether it is insulin (8, 22) or glucose (5, 42) that is the primary signal for hepatic glucose uptake under various physiological conditions.
MATERIALS AND METHODS
Experimental protocol.
Ten unanesthetized adult mongrel dogs of either sex (mean body w-t 18.5 kg) which would remain calm during the procedure were used. The dogs were randomly allocated to have either the peripheral or the portal study performed first. In the former case, the tracer was injected into a dorsal vein of the foreleg, whereas venous blood samples were obtained from a contralateral vein. For the intraportal studies, the dogs were anesthetized with sodium pentobarbital (30 mglkg); after the spleen had been removed, a polyethylene catheter was inserted into the splenic vein and externally drained through a subcutaneous passage. The cannula was washed every 8 h with heparinized warm saline. The animals were allowed to recover from surgery for 1 wk. The portal study was then conducted by giving the tracer via the catheter and collecting blood samples again from a dorsal vein of the foreleg. All dogs had been on a diet of constant composition for at least 1 wk prior to each experiment and had been fasting for 12 h when the studies were carried out.
Two dogs (3 and 5) died on the day following surgery; their portal studies are therefore lacking. A third dog (4) died 2 days after the portal experiment, and the peripheral study could not be done.
About 500 &i of [1251] insulin were administered as a single bolus; blood samples were collected at 3, 5, 10, 15, 20, 30, 40, 90, and 120 low2 pmol of insulin were added to 2.2 mCi of carrier-free lzsI (Saclay, France) and 0.5 x 1W2 pmol of KI in phosphate buffer, pH 7.4, to a final volume of 1 ml, and electrolyzed in a platinum cell by a constant current of 5 PA for 20-25 min. A lo-p1 aliquot of the labeling mixture was analyzed by paper electrophoresis (Whatman no. 1, Veronal buffer, pH 9.6, 0.8 mA/cm): after 45 min the strip was dried, cut into l-cm pieces, and counted,. The labeling yield thus estimated was 40-60%, and the iodination degree thereby calculated ranged from 0.04 to 0.06 mol of iodine per mole of protein.
The labeling mixture was then dialyzed against IRA 400 (anion exchange resin) in saline for 24 h; paper electrophoresis of the purified product usually showed a free iodine content of less than 1%.
Protein concentration was measured by ultraviolet absorbance at 277,5 nm on a Zeiss PM& II spectrophotometer, taking 5,000 as the mean value of E (molar extinction coef&ient) for native and iodosubstituted insulins at pH 8.7. Specific activity ranged 16-20 mCi/mg. Immunoreactivity was 85-90% both on the injected dose and on the plasma samples collected soon after injection The tracer was used within 24 h of preparation.
Analytical procedures. Blood was drawn into tubes containing ethylenediaminetetraacetate (EDTA). Plasma was promptly separated by centrifugation and stored at -20°C until assayed. Immunoprecipitable radioactivity was measured in duplicate by a modification of the double-antibody immunoprecipitation technique of Hales and Randle (14) . Guinea pig anti-insulin antibodies in excess (dilution 1:500) were added to plasma samples containing [1251] insulin, and the soluble antigen-antibody complex was precipitated with rabbit antiguinea pig gamma globulins. The precipitated complex was then collected on &cm Oxoid cellulose acetate membranes (OX0 Ltd., London).
Plasma concentration of endogenous insulin (IRI) was measured by the Hales and Randle method, with the use of [1311] insulin; the inter-and intraassay coefficients of variation were * 18 and *9%, respectively. Plasma glucose concentrations were measured by the neocuproine technique (Technicon AutoAnalyzer).
DATA ANALYSIS
The following symbols were used to indicate the experimental data: D, dose, as immunoreactive fraction of administered activity (counts/min); P(t) and P*(t), peripheral plasma [1251] insulin concentration curves after portal and after peripheral injection of the tracer, respectively (counts/min per ml); IRI, immunoreactive insulin, measured in peripheral plasma (pU/ml).
From these data, the following parameters were calculated, according to the formulas listed below. (The demonstration, computational aspects, and limitations of the equations employed are discussed in detail in the accompanying paper (33) .) Q = MCR x IRI = insulin turnover rate (mU/min); insulin turnover rate is the amount of hormone secreted by the pancreas per unit time under basal conditions; under the steady-state assumption, the turnover rate is also equal to the total amount of insulin which is degraded by all catabolic sites per unit time* MCR = D/JFP(t) dt and MCR* = D/JFP*(t) dt: metabolic clearance rate after portal and peripheral injection, respectively (mllmin). Metabolic clearance rate, that is, the ratio of turnover rate to the basal peripheral concentration of the hormone, is commonly defined as the volume of plasma entirely cleared of the hormone per unit time.
IDV = D/P(O) and IDV* = D/P* (0): initial distribution volumes after portal and peripheral administration, respectively (ml). According to the isotopic dilution principle, the initial distribution volume is the space in which the tracer is immediately distributed, assuming that the concentration in this space is uniformly equal to that in plasma. t = J;tP(t) dt/J;P(t) dt and i* = JttP*(t) dt/J;P*(t) dt: mean time of P(t) and P*(t), respectively (min). The mean transit time (or average residence time) is the time elapsing on average before a secreted molecule of insulin is destroyed, including the passage(s) through the circulation and all possible recirculation pathways. M = MCR* x IRI x f*: body insulin mass (mu). Body insulin mass is the overall amount of insulin in the whole body (both intra-and extravascular) which can be traced. h% = 100 x (MCR -MCR*)/MCR: hepatic extraction of insulin, defined under steady-state conditions as the ratio of the amount of hormone removed by the liver to the total amount that reaches the organ, per unit time. As shown in ref. 33, an estimate of hepatic extraction is given by the difference between the clearance rate value calculated after portal injection and that computed after peripheral administration.
Statistical appraisal of the differences between the means was performed by the paired-t test. Table 1 summarizes the results obtained in both the peripheral and the portal studies. The listed values include those calculated in the animals (3, 4, and 5) in which the experiment was not repeated, and those obtained in the dogs in which the portal (7) and the peripheral (8) tically analyzed to test the significance of the difference between the means. The initial distribution volume after portal introduction was significantly (P -C 0.01) greater than that calculated after peripheral injection, These are both larger than plasma volume (which can be estimated to be about 50 ml/kg in the dog). The initial distribution volume may also include that portion of the interstitial space into which insulin, as well as other small molecules, can easily and rapidly diffuse (26); however, the values of IDV can hardly be considered to be accurate, since they are very sensitive to the timing of the early samples and to the precision of the data. With regard to this, it should be considered that in our experiments, the first plasma sample was usually obtained 3 min after injection, when extravascular distribution and catabolism are already likely to have occurred to some extent. Actually, a better definition of the initial part of the plasma disappearance curve would probably yield initial distribution volumes closer to intravascular volumes.
RESULTS
The metabolic clearance rate after portal administration was significantly higher than the clearance rate calculated after peripheral injection. Hepatic extraction (h) was calculated for all paired cases; the same peripheral (or portal) value was used when two portal (or peripheral) values were available. Only the values of extraction derived from the difference between the clearance rate values after portal and peripheral injection are reported. The mean transit time after peripheral injection (f*) was not significantly different from the mean transit time after portal introduction (r).
Basal peripheral plasma insulin levels were measured before either the peripheral or the portal experiments in order to check that the animals were under comparable steady-state conditions on both occasions. It can be seen that there is no significant difference between them. The individual values of basal peripheral plasma insulin level measured during the portal studies were used to calculate the secretion rate Q, whereas mass; IDV*, earance rate portal (right $ Peripheral study performed-twice.
those obtained during the peripheral experiments were used for the computation of body insulin mass. Mean basal peripheral plasma insulin concentration was found to be 18-19 pU/ml.
By the Hales and Randle method (14), plasma IRI tends to be overestimated. This should be taken into account when a comparison is to be made between values reported by different investigators for such parameters as secretion rate and insulin mass. From the insulin secretion rate in our dogs (Q), it can be calculated that a dog of 18 kg has a basal daily output of about 7.5 U of insulin. The same dog has also a body insulin mass of about 0.127 U. Dividing the secretion rate by the insulin mass, a fractional catabolic rate of about 4%/min can be calculated.
This means that if steady-state conditions were maintained over 24 h, the body insulin pool would be completely renewed about 60 times.
Peripheral plasma glucose level decrements following tracer administration by either route remained within 10% of basal values (Fig. 1) .
DISCUSSION
The Tracer
Since the measurement of immunoprecipitable radioactivity is specific and sensitive, the use of radioiodinated insulin provides for a reliable description of the kinectics of insulin degradation, inasmuch as the system is minimally perturbed by the introduction of the tracer. In contrast, the use of "cold" insulin demands the administration of relatively large amounts of hormone in order to reach plasma levels whose deviations from base-line values are measurable by radioimmunoassay. In this latter case, simultaneous glucose infusion may be required to maintain steady-state conditions (41). Whether labeled insulin is metabolically equivalent to native insulin has been questioned.
As a matter of fact, the number of iodine atoms per molecule (36), the labeling technique with inherent oxidative and radiolytic damage (37), and the purification of the labeled product (9) are all factors supposed to affect the biologi- cal fate of radioinsulin significantly.
Izzo and his group (16, 17) have shown that heavily labeled insulin is more slowly metabolized by the rat, and the decrease in reaction rate constant parallels the decrease in biological activity. In contrast, [ 1311]insulin containing less than 1 atom of iodine per molecule is rapidly degraded to completion and retains full biological activity (16, 17, 36) . It seems therefore reasonable to conclude that the behavior of lightly iodine-labeled and unlabeled insulin are similar.
A drawback of mild iodination is the yield of relatively low specific activities. In the studies here reported, mean specific activity was about 20 mCi/mg. With a mean dose of 500 &i, some 0.6 U were administered as a single bolus; as a consequence, peripheral IRI levels after both portal and peripheral introduction of the tracer (Fig. 1) show a definite increase during the first 15-20 min, whereas they do not significantly differ from basal values for the remainder of the experimental interval. This means that the steady-state conditions of the system were not strictly fulfilled during the study. Yet, the validity of the formulas employed is not challenged if it can be shown that the metabolic fate of the labeled hormone is unaffected by changes in hormone levels. In this regard, Sherwin and co-workers (41) have recently demonstrated that the plasma disappearance curve of cold insulin does not change over a wide range (up to 300 pU/ml) of plasma insulin concentrations. This also applies to radioinsulin, as shown by Ooms et al. (31) and by us (30). Similarly, Silvers and co-authors (44) provided direct evidence for the lack of saturability of the plasma insulin removal mechanism.
The Kinetics
Metabolic clearance rate.
Our value of metabolic clearance rate after peripheral injection (MCR*) in unanesthetized dogs (13.4 t 0.9 ml/min per kg) can be (41)]. This can be taken as good (though indirect) evidence that our tracer showed a metabolic behavior quite close to that of native insulin.
In contrast, Silvers and co-workers (43), by injection of a single bolus of [1311] insulin into peripheral veins of anesthetized dogs, found a fractional irreversible loss rate from plasma of 0.052 * 0.003% min? As they estimated the plasma volume to be approximately 5.3% of body weight, the clearance rate value can be calculated as about 2.8 mllmin per kg. Giving the same radioiodinated insulin to normal subjects, they found a fractional loss rate of 0.055 k 0.003, from which, if a mean plasma volume of 3 liters is taken, a clearance rate value of 165 mllmin or 2.4 ml/min per kg is obtained (44).
Thus, Silvers' clearance figures are 4-5 times lower, both in man and in the dog; this discrepancy, which cannot be explained by differences in the experimental and computational methods, might be a result of the use of somewhat damaged radioinsulin, which is known to be catabolized at a slower rate (16).
Insulin turnover rate was calculated as the product of basal plasma insulin levels (IRI) and the clearance rate, as estimated by portal injection of the tracer (MCR). The extent to which insulin is extracted by the liver is a rather unsettled subject as yet, and conflicting results have been reported by various investigators (27). Rubenstein and co-workers (39) found a hepatic clearance of about 4 ml/min in rat livers perfused at a flow of 24 ml/min with blood Erom fed rats; this value, which corresponds to an extraction of 17%, was constant over a wide range of perfusate insulin concentrations (up to 180 rig/ml). Similarly, Ooms et al. (31) found that E repatic removal of [lz51]insulin was Zl-23% in the anesthetized dog until portal insulin concentrations of 1,000 pU/ml: in these experiments, plasma glucose levels were kept constant by glucose administration. Waddel and Sussman (47) also reported that insulin is taken up by the liver to only a "minimal" extent under basal conditions. In contrast, values of basal hepatic extraction from 40 to 55% have been reported in the rat (29), in the dog (18), and in man (24, 25). in addition, also the hormone possibly bound to the liver in a reversible manner was considered as extracted. A second difficulty is that of streaming in the portal vein; any material injected into a single tributary of the portal vein will not be distributed uniformly throughout the liver because the flow in the portal vein is not turbulent.
This should introduce only minimal uncertainty into the estimates of hepatic parameters, unless major heterogeneities of degrading systems exist within the liver. However, this method represents the first approach to the estimation of liver catabolism by an in vivo procedure.
When the plasma disappearance curves after both portal and peripheral introduction . of the tracer are recorded for 2 h, as described in this paper, 1 ver extraction can be estimated from the difference between the calculated clearance rate values as well as from the difference between the initial distribution volumes. Our data supply a value of 19.6% (range 9536.2%) by the former approach and 22.2% (range O-45%) by the latter approach; it can be seen that the first measure, derived from integral properties of the curve, is much more precise. On the same rationale is based the recently reported method of Gurpide et al. (12) , which consists in simultaneous infusion of two tracers of progesterone into a peripheral vein and upstream to the liver. The physiological meaning of these experiments must be carefully appraised; in fact, a direct effect of portal insulin level on hepatic extraction has been postulated, even if the direction of such an effect is controversial. As a matter of fact, Kaplan and Madison (20) concluded that infusion of 9 g of glucose diminished hepatic insulin retention from 54 to 38%, and a further reduction to 7.8% is attained when 52 g of glucose are infused over 165 min. The results of Meade et al. (27) are also consistent with the hypothesis that feeding decreases hepatic extraction of insulin. On the other hand, Kaden et al.
(18) and Waddel and Sussman (47) provided evidence that glucose administration increases hepatic retention of insulin.
In our experiments, non-negligible amounts of cold insulin were administered because of low specific activity tracer, as already discussed. The peripheral IRI value after both portal and peripheral injections are depicted in Fig. 1 ; the peripheral IRI curve after an intravenous glucose load in dog 1 is also shown for comparison. It can be seen that the peak values after exogenous administration and glucose stimulus are similar, even though the area under the glucose-induced insulin curve is actually larger. It can be inferred that portal insulin concentrations reached approximately the same peak values under both conditions, even though a larger load of insulin is offered to the liver in case of glucose administration.
Thus, we conclude that our hepatic extraction value refers to a physiologic range of portal insulin concentrations and, since glucose levels were not appreciably changed following tracer administration, it relates to basal conditions. On the basis of our data, we cannot rule out that simultaneous variations of insulin and substrates (e,g. glucose) may induce a different, either higher or lower, heyatic extraction of insulin.
It should a&o be underlined that in all cited studies, the range of values of hepatic retention is wide, occasionally extreme (18); we too found rather scattered values (9&-36.2%). Two explanations may be offered: a> there are marked differences in liver catabolic rate among i&ividuals of the same species; b) there is considerable variation in the experimental conditions even in the same set of experiments.
Though the latter explanation seems more likely, the former hypothesis would imply that the measurement of clearance rate by peripheral administration of either tracer or cold insulin does not provide for a direct estimation of secretion rate.
Hepatic
catabolism.
When hepatic extraction is known, the overall amount of hormone degraded by the liver per unit time can be calculated considering that hepatic extraction applies not only to de novo synthetized hormone but also to recirculating insulin (33). Using our value of about 20% for hepatic retention and a value of 21.5 mllmin per kg for total hepatic plasma flow in the dog (ll), about 48% of secreted insulin is degraded by the liver. From the data of Sherwin et al. (41), who choose a value of hepatic extraction of 47% and a value of total hepatic plasma flow of 840 mllmin in man, about 74% of secreted insulin is catabolized by the liver. These figures stress the prominent role of the liver in insulin catabolism under basal conditions,
The percentage values of hepatic insulin catabolism might seem to be in contrast with the fact that hepatic insulin clearance rate is only one-fourth of the total clearance rate both in man (400 vs. 1,470 mllmin) and in the dog (4.3 vs. 15.1 ml/min per kg). In this regard, it should be emphasized that the overall clearance rate of any compound can be estimated as the sum of several organ clearance rates independently measured only if all the metabolicaily active organs are connected in a parallel fashion, i.e., they all receive the compound at the same plasma concentration. Since the liver receives the pancreatic hormones at a greater concentration than all other organs and tissues (kidney, muscle, adipose tissue, etc.), its clearance rate has to be weighted by the ratio of hepatic to peripheral concentration,
The working concentration of insulin in the liver can be obtained considering that both newly secreted insulin and recirculated hormone are diluted in the total hepatic plasma flow. From our data, a hepatic concen-them must be referred to its own concentration.
Insdin nzass. Turnover rate and mean transit time combine to yield an estimation of body insulin mass, which is relevant kinetic information.
By injecting the tracer both into the portal and into the peripheral circulations, we obtained two values (f and f*) of mean transit time; it is clear (cf. 33) that the difference between them, engendered by a single transhepatic passage, should be equal to the mean hepatic transit time.
Our results failed to show any significant difference between f and f*, mainly because of marked fluctuations of the measurements.
However, it is reasonable to think that greater differences would have been detected; so it could also be inferred that hepatic transit time is short in comparison with peripheral transit time. In any case, the fraction (1 -h) of hormone which overpasses the liver has a mean residence time f* and in respect to this fraction the liver is connected like all other catabolic sites. If an assumption is made that hepatic mean transit time is short in comparison with the mean transit time of the hormone reaching the periphery (f*), an estimate of body insulin mass can be obtained from peripheral studies only (cf. DATA ANALYSIS).
The unique constraint is that the mass of all insulin molecules extracted at the first transhepatic passage is not included. The turnover rate of these molecules (h x Q) may represent a conspicuous moiety of the overall turnover rate, but since, by assumption, their life-time (i.e., hepatic mean transit time) is short, their contribution to total insulin mass is relatively small. In conclusion, we believe that this double-injection method is most rewarding as it supplies estimates of insulin kinetic parameters virtually superimposable on those obtained by other more complicated techniques, which demand direct measurement of blood flows and insulin concentrations before and immediately beyond the organ. In addition, since the portal vein can be cannulated via the umbilical vein under local anesthesia in humans (4), this technique could also be applied to investigations in man, and modeling the insulin system can be therefore extended to include adequate consideration of the handling of insulin by the liver.
